PURPOSE: Difference in the quality of care may contribute to the less optimal prostate cancer treatment outcomes among black men compared with white men. We determined whether a racial quality of care gap exists in surgical care for prostate cancer, as evidenced by racial variation in the use of high volume surgeons and facilities, and in the quality of certain outcome measures of care. MATERIALS AND METHODS: We performed cross-sectional and cohort analyses of administrative data from the Healthcare Cost and Utilization Project all-payer State Inpatient Databases, encompassing all nonfederal hospitals in Florida, Maryland and New York State from 1996 to 2007. Included in analysis were men 18 years old or older with a diagnosis of prostate cancer who underwent radical prostatectomy. We compared the use of surgeons and/or hospitals in the top quartile of annual volume for this procedure, inpatient blood transfusion, complications, mortality and length of stay between black and white patients. RESULTS: Of 105,972 patients 81,112 (76.5%) were white, 14,006 (13.2%) were black, 6,999 (6.6%) were Hispanic and 3,855 (3.6%) were all other. In mixed effects multivariate models, black men had markedly lower use of high volume hospitals (OR 0.73, 95% CI 0.70-0.76) and surgeons (OR 0.67, 95% CI 0.64-0.70) compared to white men. Black men also had higher odds of blood transfusion (OR 1.08, 95% CI 1.01-1.14), longer length of stay (OR 1.07, 95% CI 1.06-1.07) and inpatient mortality (OR 1.73, 95% CI 1.02-2.92). CONCLUSIONS: Using an all-payer data set, we identified concerning potential quality of care gaps between black and white men undergoing radical prostatectomy for prostate cancer.
PURPOSE: Difference in the quality of care may contribute to the less optimal prostate cancer treatment outcomes among black men compared with white men. We determined whether a racial quality of care gap exists in surgical care for prostate cancer, as evidenced by racial variation in the use of high volume surgeons and facilities, and in the quality of certain outcome measures of care. MATERIALS AND METHODS: We performed cross-sectional and cohort analyses of administrative data from the Healthcare Cost and Utilization Project all-payer State Inpatient Databases, encompassing all nonfederal hospitals in Florida, Maryland and New York State from 1996 to 2007. Included in analysis were men 18 years old or older with a diagnosis of prostate cancer who underwent radical prostatectomy. We compared the use of surgeons and/or hospitals in the top quartile of annual volume for this procedure, inpatient blood transfusion, complications, mortality and length of stay between black and white patients. RESULTS: Of 105,972 patients 81,112 (76.5%) were white, 14,006 (13.2%) were black, 6,999 (6.6%) were Hispanic and 3,855 (3.6%) were all other. In mixed effects multivariate models, black men had markedly lower use of high volume hospitals (OR 0.73, 95% CI 0.70-0.76) and surgeons (OR 0.67, 95% CI 0.64-0.70) compared to white men. Black men also had higher odds of blood transfusion (OR 1.08, 95% CI 1.01-1.14), longer length of stay (OR 1.07, 95% CI 1.06-1.07) and inpatient mortality (OR 1.73, 95% CI 1.02-2.92). CONCLUSIONS: Using an all-payer data set, we identified concerning potential quality of care gaps between black and white men undergoing radical prostatectomy for prostate cancer.
Authors: L C Harlan; A Potosky; F D Gilliland; R Hoffman; P C Albertsen; A S Hamilton; J W Eley; J L Stanford; R A Stephenson Journal: J Natl Cancer Inst Date: 2001-12-19 Impact factor: 13.506
Authors: Colin B Begg; Elyn R Riedel; Peter B Bach; Michael W Kattan; Deborah Schrag; Joan L Warren; Peter T Scardino Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: Paul A Godley; Anna P Schenck; M Ahinee Amamoo; Victor J Schoenbach; Sharon Peacock; Michelle Manning; Michael Symons; James A Talcott Journal: J Natl Cancer Inst Date: 2003-11-19 Impact factor: 13.506
Authors: Nina A Bickell; Jenny J Lin; Sarah R Abramson; Gerald P Hoke; William Oh; Simon J Hall; Richard Stock; Kezhen Fei; Ann Scheck McAlearney Journal: J Oncol Pract Date: 2017-12-01 Impact factor: 3.840
Authors: Nicholas M Donin; Stacy Loeb; Phillip R Cooper; Kimberly A Roehl; Nikola A Baumann; William J Catalona; Brian T Helfand Journal: BJU Int Date: 2014-07-15 Impact factor: 5.588
Authors: Raj Satkunasivam; Mary Lo; Mariana Stern; Inderbir S Gill; Steven Fleming; Xiao-Cheng Wu; Roger T Anderson; Trevor D Thompson; Ann S Hamilton Journal: Am J Clin Oncol Date: 2018-11 Impact factor: 2.339
Authors: Daniel C Parker; Elizabeth Handorf; Marc C Smaldone; Robert G Uzzo; Henry Pitt; Adam C Reese Journal: Urol Oncol Date: 2017-09-01 Impact factor: 3.498
Authors: Alex Tsodikov; Roman Gulati; Tiago M de Carvalho; Eveline A M Heijnsdijk; Rachel A Hunter-Merrill; Angela B Mariotto; Harry J de Koning; Ruth Etzioni Journal: Cancer Date: 2017-04-24 Impact factor: 6.860
Authors: Regina M Simeone; Matthew E Oster; Cynthia H Cassell; Brian S Armour; Darryl T Gray; Margaret A Honein Journal: Birth Defects Res A Clin Mol Teratol Date: 2014-06-27
Authors: Marianne Schmid; Christian P Meyer; Gally Reznor; Toni K Choueiri; Julian Hanske; Jesse D Sammon; Firas Abdollah; Felix K H Chun; Adam S Kibel; Reginald D Tucker-Seeley; Philip W Kantoff; Stuart R Lipsitz; Mani Menon; Paul L Nguyen; Quoc-Dien Trinh Journal: JAMA Oncol Date: 2016-01 Impact factor: 31.777
Authors: Feng Qian; Michael P Eaton; Stewart J Lustik; Samuel F Hohmann; Carol B Diachun; Robert Pasternak; Richard N Wissler; Laurent G Glance Journal: BMC Health Serv Res Date: 2014-03-11 Impact factor: 2.655